TGA Paying Pan Pharma $55M

Pan Pharmaceuticals will receive $55 million from the Therapeutic Goods Administration (TGA) under terms of a settlement ratified in Australian court, after the federal agency recalled the company’s product suite in 2003, it was reported by NutraIngredients.com.

Source: NutraIngredients.com: Australian regulator pays Pan $55m after recall rethink